Shift Bioscience establishes North American facilities to expand capabilities of AI-powered virtual cell technology

Shift Bioscience, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the establishment of a new North American team and facilities to advance development of the Company’s platform for discovery of rejuvenation gene targets.

Revolutionising CF treatment: advances, challenges, prospects

Cystic fibrosis (CF) is an autosomal recessive disease characterised by its effects on pancreatic function and persistent airway infections. Mutations in the CF transmembrane conductance

June 6, 2024

QL-401 by QLSF Biotherapeutics for Relapsed Acute Myeloid Leukemia: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

January 6, 2025

Study shows how social media fuels unhappiness and materialism

You won’t find another place that makes it as easy to compare yourself with others as social media. That’s not good for you.

January 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.